BioCentury
ARTICLE | Company News

Adolor, University of Chicago deal

December 18, 2000 8:00 AM UTC

ADLR obtained from the university an exclusive worldwide license to U.S. Patent No. 6,096,513 and patent applications covering the nucleotide sequence of the mammalian kappa opioid receptor and relat...